Sorbus Advisors LLC

About
Services
Professionals
Resources
Blog
Contact

2015 Goodwill / Intangibles Benchmarking BioPharmaceuticals

December 15, 2016 | by Max Fonarev

Recent Posts

What M&A Purchase Consideration Is Actually Worth?
Covid-19 | Valuation Update | Three Months In
COVID-19 | Valuation Update
Valuing VC Investments – An Intuitive Example
Valuation Market Multiples: Not So Simple

Labels

Tax Compliance Fair Value Financial Instruments Fair Market Value Life Sciences Financial Reporting Tax Valuation Purchase Price Allocation Transactions 409A Valuation ASC 805 Purchase Accounting Business Interests Term Sheet Purchase Accounting ASC 805 IP Valuation Intangible Asset Valuation Portfolio Valuation

Twitter
Linkedin

© 2021 Sorbus Advisors LLC. All Rights Reserved. | Terms of Use | Privacy Policy

Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.

First Name*
Last Name*
Company
Newsletter Sign up*